These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1127 related articles for article (PubMed ID: 19204465)
1. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465 [TBL] [Abstract][Full Text] [Related]
2. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615 [TBL] [Abstract][Full Text] [Related]
3. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309 [TBL] [Abstract][Full Text] [Related]
4. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors. Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357 [TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification. Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519 [TBL] [Abstract][Full Text] [Related]
6. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N; Dávila J; Medrano J; Olmos S Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889 [TBL] [Abstract][Full Text] [Related]
7. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325 [TBL] [Abstract][Full Text] [Related]
8. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370 [TBL] [Abstract][Full Text] [Related]
9. In vivo proton spectroscopy of giant cell tumor of the bone. Sah PL; Sharma R; Kandpal H; Seith A; Rastogi S; Bandhu S; Jagannathan NR AJR Am J Roentgenol; 2008 Feb; 190(2):W133-9. PubMed ID: 18212197 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Fayad LM; Barker PB; Bluemke DA Semin Musculoskelet Radiol; 2007 Sep; 11(3):240-5. PubMed ID: 18260034 [TBL] [Abstract][Full Text] [Related]
11. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas. Fayed N; Morales H; Modrego PJ; Pina MA Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275 [TBL] [Abstract][Full Text] [Related]
12. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla. Booth SJ; Pickles MD; Turnbull LW BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962 [TBL] [Abstract][Full Text] [Related]
13. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245 [TBL] [Abstract][Full Text] [Related]
14. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors. Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla. Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417 [TBL] [Abstract][Full Text] [Related]
16. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence]. Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282 [TBL] [Abstract][Full Text] [Related]
17. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma. Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456 [TBL] [Abstract][Full Text] [Related]
18. Quantitative multivoxel proton chemical shift imaging of the breast. Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119 [TBL] [Abstract][Full Text] [Related]
19. [In vivo proton MR spectroscopy of normal liver parenchyma: technique and results]. Müller C; Hübner F; Bisdas S; Herzog C; Hammerstingl RM; Ackermann H; Vorbuchner M; Vogl TJ Rofo; 2006 Nov; 178(11):1128-36. PubMed ID: 17128381 [TBL] [Abstract][Full Text] [Related]
20. Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors. Ikehira H; Miyamoto T; Yasukawa T; Obata T; Katoh H; Koga M; Yoshikawa K; Yoshida K; Tateno Y Radiat Med; 1995; 13(5):199-204. PubMed ID: 8848553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]